Published in Medical Letter on the CDC and FDA, July 11th, 2004
"Mixed-valent films of ruthenium oxide-ruthenium cyanide were electrodeposited onto glassy carbon and characterized for the electrocatalytic oxidation of tetracycline. The currents produced by tetracycline were higher than from previously reported electrode modifications or pretreatments. In H2 SO4 pH 1.0 + 0.5M K2 SO4 , the second-order rate constant for the reaction between tetracycline and the Ru(III/IV) couple of ruthenium oxide was 3x105±1x105...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.